glp-1 obesity drug news october 9 2025 Outlook for in 2026: From Consolidation to Acceleration Lilly hikes revenue forecasts on

Regular updates of Price Comparisons for REGISTERED providers of Prescription only Medication in the UK

Hydration requires deliberate attention

"Treatment with semaglutide, at low doses, significantly reduces body weight in almost 80% of obese PCOS patients who were unresponsive to a previous lifestyle plan." - Enrico Carmina, MD This highlights how critical it is to stay consistent with treatment to achieve and maintain these results

GLP-1 drugs are authorised for weight loss, and none are intended for cosmetic or aesthetic uses

Patients receive personalized care and ongoing medical support, with treatment options designed for long-term weight management

There is a difference